Human Respiratory Syncytial Virus and Coronavirus Rates in Iranian Elderly Patients More than 60 Years Old with Acute Respiratory Symptoms.

Advanced Biomedical Research Pub Date : 2023-01-01 DOI:10.4103/abr.abr_395_22

Shaian Tavakolian, Hossein Goudarzi, Ilad Alavi Darazam, Ebrahim Faghihloo

{"title":"Human Respiratory Syncytial Virus and Coronavirus Rates in Iranian Elderly Patients More than 60 Years Old with Acute Respiratory Symptoms.","authors":"Shaian Tavakolian, Hossein Goudarzi, Ilad Alavi Darazam, Ebrahim Faghihloo","doi":"10.4103/abr.abr_395_22","DOIUrl":null,"url":null,"abstract":"Background: Scientists have believed that a number of risk factors, especially viral infectious agents, can be related to respiratory diseases. Due to the pandemics in 2019, Human Respiratory Syncytial Virus and Coronavirus have attracted the attention of different kinds of research. In this study, we attempted to evaluate the prevalence of these viruses.Materials and methods: After extracting the RNA and DNA of these viruses, molecular tests were employed to report the rate of them in patients suffering from respiratory symptoms.Results: Our results demonstrated that 31 samples were COVID-19 positive. Furthermore, two cases had Respiratory syncytial virus (RSV) subgroup A infections. However, no cases showed a coinfection of both viruses.Conclusions: It seems that during the pandemic of COVID-19, RSV should not be ignored as it can be responsible for the respiratory syndrome.","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"180"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/fc/ABR-12-180.PMC10492601.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Biomedical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/abr.abr_395_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Scientists have believed that a number of risk factors, especially viral infectious agents, can be related to respiratory diseases. Due to the pandemics in 2019, Human Respiratory Syncytial Virus and Coronavirus have attracted the attention of different kinds of research. In this study, we attempted to evaluate the prevalence of these viruses.

Materials and methods: After extracting the RNA and DNA of these viruses, molecular tests were employed to report the rate of them in patients suffering from respiratory symptoms.

Results: Our results demonstrated that 31 samples were COVID-19 positive. Furthermore, two cases had Respiratory syncytial virus (RSV) subgroup A infections. However, no cases showed a coinfection of both viruses.

Conclusions: It seems that during the pandemic of COVID-19, RSV should not be ignored as it can be responsible for the respiratory syndrome.

查看原文本刊更多论文

伊朗60岁以上急性呼吸道症状老年人呼吸道合胞体病毒和冠状病毒感染率

背景:科学家们认为，许多危险因素，特别是病毒感染因子，可能与呼吸系统疾病有关。由于2019年的大流行，人类呼吸道合胞病毒和冠状病毒引起了各种研究的关注。在这项研究中，我们试图评估这些病毒的流行程度。材料和方法:提取这些病毒的RNA和DNA后，采用分子检测报告其在呼吸道症状患者中的感染率。结果:31份样本呈COVID-19阳性。2例呼吸道合胞病毒(RSV) A亚群感染。然而，没有病例显示两种病毒同时感染。结论:在2019冠状病毒病(COVID-19)大流行期间，RSV可能是呼吸道综合征的病因，不容忽视。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advanced Biomedical Research

自引率

0.00%

发文量